Molecular characterization of putative chordoma cell lines.
Immortal tumor cell lines are an important model system for cancer research, however, misidentification and cross-contamination of cell lines are a common problem. Seven chordoma cell lines are reported in the literature, but none has been characterized in detail. We analyzed gene expression patterns and genomic copy number variations in five putative chordoma cell lines (U-CH1, CCL3, CCL4, GB60, and CM319). We also created a new chordoma cell line, U-CH2, and provided genotypes for cell lines for identity confirmation. Our analyses revealed that CCL3, CCL4, and GB60 are not chordoma cell lines, and that CM319 is a cancer cell line possibly derived from chordoma, but lacking expression of key chordoma biomarkers. U-CH1 and U-CH2 both have gene expression profiles, copy number aberrations, and morphology consistent with chordoma tumors. These cell lines also harbor genetic changes, such as loss of p16, MTAP, or PTEN, that make them potentially useful models for studying mechanisms of chordoma pathogenesis and for evaluating targeted therapies.
Institute of Pathology, Ulm University, D-89081 Ulm, Germany.
Silke
S
Brüderlein
Joshua B
JB
Sommer
Paul S
PS
Meltzer
Sufeng
S
Li
Takuya
T
Osada
David
D
Ng
Peter
P
Möller
David A
DA
Alcorta
Michael J
MJ
Kelley
Genome Biol. 2005;6(9):R76
16168083
J Mol Histol. 2004 Mar;35(3):255-62
15339045
Int J Cancer. 1999 Nov 12;83(4):555-63
10508494
In Vitro Cell Dev Biol Anim. 2003 Nov-Dec;39(10):424-7
14753847
Hum Pathol. 1998 Feb;29(2):119-26
9490269
Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14863-8
9843981
J Pathol. 2006 Jun;209(2):157-65
16538613
Leukemia. 2003 Feb;17(2):416-26
12592342
Radiat Oncol. 2009 Jun 02;4:16
19490617
J Pathol. 2010 Apr;220(5):608-17
20140939
J Natl Cancer Inst. 2010 Feb 24;102(4):271-4
20075370
EMBO J. 1995 Oct 2;14(19):4763-72
7588606
In Vitro Cell Dev Biol Anim. 1998 Jan;34(1):1-8
9542623
Mod Pathol. 2008 Dec;21(12):1461-9
18820665
Mol Cancer Ther. 2009 Sep;8(9):2597-605
19723879
Br J Cancer. 2009 May 5;100(9):1406-14
19401700
Zhonghua Zhong Liu Za Zhi. 2003 May;25(3):234-7
12839683
Clin Cancer Res. 2003 Sep 15;9(11):4227-39
14519650
Curr Opin Oncol. 2007 Jul;19(4):367-70
17545801
Cancer Res. 2002 Aug 1;62(15):4427-33
12154050
Cancer. 1970 May;25(5):1204-15
5443740
Nature. 2006 Jan 19;439(7074):353-7
16273092
Genes Chromosomes Cancer. 2001 Nov;32(3):203-11
11579460
Cancer Causes Control. 2001 Jan;12(1):1-11
11227920
Acta Neuropathol. 1975 Aug 27;32(3):225-33
1101623
Biostatistics. 2003 Apr;4(2):249-64
12925520
Genomics. 2005 Aug;86(2):127-41
15950434
Br J Cancer. 2001 May 18;84(10):1424-31
11355958
Acta Neuropathol. 1976 May 18;35(1):13-25
1274529
Nat Genet. 2009 Nov;41(11):1176-8
19801981
PLoS Med. 2007 Feb;4(2):e60
17298169
J Neurosurg. 2006 Sep;105(3):482-4
16961149
Neurosurg Focus. 2003 Aug 15;15(2):E9
15350040
Cancer. 2004 Nov 1;101(9):2086-97
15372471
Ann Biomed Eng. 2005 Aug;33(8):1071-7
16133915
Cancer Immunol Immunother. 2009 Mar;58(3):339-49
18641983
Am J Pathol. 2001 May;158(5):1571-8
11337353
Dev Dyn. 2008 Dec;237(12):3953-8
19035356
J Lipid Res. 1998 Feb;39(2):369-79
9507997
Am J Surg Pathol. 2008 Apr;32(4):572-80
18301055
Bioinformatics. 2003 Jan 22;19(2):185-93
12538238
Spine (Phila Pa 1976). 2007 Dec 15;32(26):2957-64
18091487
Spine (Phila Pa 1976). 2008 Dec 1;33(25):2774-80
19050584
Cancer Res. 2006 Apr 15;66(8):4167-72
16618738
Clin Cancer Res. 2007 Apr 15;13(8):2471-8
17438107
Clin Cancer Res. 2009 Mar 15;15(6):1940-6
19276265
Br J Cancer. 2008 Jan 29;98(2):434-42
18071362
J Clin Oncol. 2005 May 20;23(15):3597-604
15908670